Digital Marketing Trends in Age-Related Macular Degeneration
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Digital Marketing Trends in Age-Related Macular Degeneration Report Overview
Bayerโs Eylea.us achieved the highest total traffic across age-related macular degeneration (AMD) branded patient sites in the US from May 2022 to April 2023. This was followed by Genentechโs Vabysmo.com and Lucentis.com. Overall, the highest proportion of traffic to top branded patient AMD websites originated from organic sources, followed by direct. Novartisโsย Beovu.com had the highest proportion of organic traffic, followed by Lucentis.com.
The Digital Marketing Trends in the Age-Related Macular Degeneration research report assess key digital marketing metrics of pharma assets in Age-Related Macular Degeneration (AMD), including branded websites for patients and healthcare professionals (HCPs), unbranded websites, and social media accounts. The report offers metrics on website traffic volume, engagement, source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction. Moreover, the countries analyzed in the report are the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Key US Patient-Branded Websites | ยทย ย ย ย ย ย Eylea.us
ยทย ย ย ย ย ย Vabysmo.com ยทย ย ย ย ย ย Lucentis.com ยทย ย ย ย ย ย Susvimo.com ยทย ย ย ย ย ย Beovu.com |
Key US HCP Branded Websites | ยทย ย ย ย ย ย Vabysmo-hcp.com
ยทย ย ย ย ย ย Susvimo-hcp.com ยทย ย ย ย ย ย Eylea4ueportal.com ยทย ย ย ย ย ย Byoovizhcp.com ยทย ย ย ย ย ย Beovuhcp.com ยทย ย ย ย ย ย Cimerli.com |
Key EUCAN Branded Websites | ยทย ย ย ย ย ย Eylea.co.uk
ยทย ย ย ย ย ย Vabysmo.ca |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Major US Patient Branded Websites for Age-Related Macular Degeneration
The major US patient-branded websites for Age-Related Macular Degeneration are Eylea.us, Vabysmo.com, Lucentis.com, Susvimo.com, and Beovu.com. Bayerโs Eylea.us achieved the highest total traffic across AMD patient sites in the US from May 2022 to April 2023, followed by Genentechโs Vabysmo.com and Lucentis.com.
Traffic Share to Branded US AMD Patient Sites, May 2022 โ April 2023 (%)
ย For more insights into the total traffic share of the US patient-branded websites, download a free report sample
Major US HCP Branded Websites for Age-Related Macular Degeneration
The major US HCP-branded websites for Age-Related Macular Degeneration are Vabysmo-hcp.com, Susvimo-hcp.com, Eylea4ueportal.com, Byoovizhcp.com, Beovuhcp.com, and Cimerli.com. Genentechโs Vabysmo-hcp.com achieved the highest total traffic across HCP sites in the US, from May 2022 to April 2023, followed by Genentechโs Susvimo-hcp.com. Byoovizhcp.com achieved the highest average visit duration and Eylea4ueportal.com had the highest pages per visit as well as the lowest bounce rate.
Traffic Share to Branded US AMD HCP Sites, May 2022 โ April 2023 (%)
For more insights into the total traffic share of the US HCP branded websites, download a free report sample
Top US Social Media Activity in Age-Related Macular Degeneration
Between May 2022 and April 2023, approximately 140 social media posts related to AMD were detected from pharma in the US, including Outlook Therapeutics, Regeneron, Bausch & Lomb, Genentech, and Apellis Pharmaceuticals. Among them, Outlook Therapeutics posted the most AMD content on its corporate Twitter account. The post with the highest interaction promoted the EMA validation of the marketing authorization application (MAA) for Outlook Therapeuticsโs ONS-5010 (bevacizumab) for the treatment of wet AMD.
Major EUCAN Branded Websites for Age-Related Macular Degeneration
Few branded sites for AMD were detected in EUCAN. The ones detected are Eylea.co.uk and Vabysmo.ca. Traffic to detected sites was low, with visits to Bayerโs Eylea.co.uk (currently offline) in the lead.
Traffic Share to Branded EUCAN AMD Sites, May 2022 โ April 2023 (%)
For more insights into the total traffic share of the EUCAN-branded websites, download a free report sample
Top EUCAN Social Media Activity in Age-Related Macular Degeneration
Between May 2022 and April 2023, more than 45 social media posts related to AMD were detected from pharma in EUCAN, predominantly Roche and Novartis. Roche had the most AMD posts across its various local language corporate accounts, with the majority coming from the Roche Espana Twitter account.
Scope
This report assesses key digital marketing metrics of pharma assets in age-related macular degeneration (AMD), including branded websites for patients and healthcare professionals (HCPs), unbranded websites, and social media accounts. Metrics include website traffic volume, engagement, and source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction. Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Reasons to Buy
- Understand the digital marketing competitive landscape in AMD, with a view to leading patient and HCP branded assets across different regions.
- See what tactics pharma companies are using to drive traffic to their AMD branded and unbranded assets for patients and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded assets for patients by how they address and support different patient needs.
- See what pharma social media accounts in AMD are the most active and achieving the most engagement.
Genentech
Novartis
Coherus Biosciences
Bausch & Lomb
Apellis Pharmaceuticals
Outlook Therapeutics
Table of Contents
Frequently asked questions
-
Which is the leading US patient-branded website for Age-Related Macular Degeneration?
Eylea.us is the leading US patient-branded website for Age-Related Macular Degeneration.
-
Which is the leading US HCP-branded website for Age-Related Macular Degeneration?
Vabysmo-hcp.com is the leading US HCP-branded website for Age-Related Macular Degeneration.
-
Which is the leading EUCAN-branded website for Age-Related Macular Degeneration?
Eylea.co.uk is the leading EUCAN-branded website for Age-Related Macular Degeneration.

Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customerโs requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Age Related Macular Degeneration reports

